Owned by Biotech parent company Atai Life Sciences, COMPASS is a biotechnology mental health care company. We are dedicated to accelerating patient access to evidence-based innovation in mental health.
Our first major initiative is developing psilocybin therapy through late-stage clinical trials in Europe and North America for people with treatment-resistant depression.